{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:55:32Z","timestamp":1793973332144,"version":"4.8.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lanepe.2024.101171","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:36:41Z","timestamp":1739990201000},"page":"101171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Mapping the landscape of biliary tract cancer in Europe: challenges and controversies"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-3615","authenticated-orcid":false,"given":"Lorenza","family":"Rimassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1917-6973","authenticated-orcid":false,"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-5244","authenticated-orcid":false,"given":"Jesper B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9764-4771","authenticated-orcid":false,"given":"Chiara","family":"Gabbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob N.","family":"Kather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5641-1330","authenticated-orcid":false,"given":"Irene","family":"Bargellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Morement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-0777","authenticated-orcid":false,"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi A.","family":"Farazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-2519","authenticated-orcid":false,"given":"Guido","family":"Carpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias A.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Saborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-0326","authenticated-orcid":false,"given":"Rocio I.R.","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lanepe.2024.101171_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/cco.2019.08.03","article-title":"Epidemiology of gallbladder cancer in India","volume":"8","author":"Dutta","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12885-024-12279-6","article-title":"Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic","volume":"24","author":"Zanuso","year":"2024","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib5","article-title":"Cholangiocarcinoma across England: temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation","volume":"6","author":"Tataru","year":"2024","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib6","first-page":"349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101171_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1055-9965.EPI-21-0265","article-title":"Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, Race\/Ethnicity, and stage at diagnosis: United States, 2013 to 2017","volume":"30","author":"Ellington","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"10.1016\/j.lanepe.2024.101171_bib8","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3748\/wjg.v29.i24.3825","article-title":"Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017","volume":"29","author":"Zalin-Miller","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101171_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005720","article-title":"A\u00a0case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer","volume":"4","author":"Keane","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100377","article-title":"Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"7","author":"Casadio","year":"2022","journal-title":"ESMO Open"},{"issue":"Suppl 1","key":"10.1016\/j.lanepe.2024.101171_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","article-title":"Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017","volume":"27","author":"Javle","year":"2022","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jhep.2019.07.024","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Khan","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/liv.13998","article-title":"Classifications and misclassification in cholangiocarcinoma","volume":"39","author":"Cardinale","year":"2019","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186643","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based study in SEER-Medicare","volume":"12","author":"Petrick","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.28529","article-title":"Aspirin use and the risk of cholangiocarcinoma","volume":"64","author":"Choi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1478-3231.2009.02149.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China","volume":"30","author":"Tao","year":"2010","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/ijc.28196","article-title":"Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism","volume":"133","author":"Zhou","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3748\/wjg.14.632","article-title":"Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China","volume":"14","author":"Zhou","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ije\/25.5.933","article-title":"Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea","volume":"25","author":"Shin","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.lanepe.2024.101171_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"Yamamoto","year":"2004","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ejca.2010.02.005","article-title":"Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis","volume":"46","author":"Zhou","year":"2010","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/liv.12618","article-title":"Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study","volume":"35","author":"Lee","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CEJ.0000000000000468","article-title":"Risk factors for extrahepatic cholangiocarcinoma: a case-control study in China","volume":"28","author":"Zhou","year":"2019","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ueg2.12154","article-title":"Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland","volume":"9","author":"Barner-Rasmussen","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib32","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.lanepe.2024.101171_bib33","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1572-0241.2008.01796.x","article-title":"Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study","volume":"103","author":"Lee","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2005.11.040","article-title":"Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea","volume":"44","author":"Choi","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib35","doi-asserted-by":"crossref","first-page":"e1392","DOI":"10.1093\/cid\/ciac497","article-title":"Opisthorchis felineus infection is a risk factor for cholangiocarcinoma in Western Siberia: a hospital-based case-control study","volume":"76","author":"Fedorova","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.26092","article-title":"Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk","volume":"57","author":"Chaiteerakij","year":"2013","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101171_bib38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","article-title":"Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma","volume":"100","author":"Lee","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lanepe.2024.101171_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.lanepe.2024.101171_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3417976","article-title":"HBV infection status and the risk of cholangiocarcinoma in Asia: a meta-analysis","volume":"2016","author":"Zhang","year":"2016","journal-title":"BioMed Res Int"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib41","first-page":"911","article-title":"Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case-control analysis","volume":"24","author":"Brandi","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib42","first-page":"42","article-title":"New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin","volume":"31","author":"Bragazzi","year":"2018","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/j.gastro.2020.06.037","article-title":"Asbestos exposure and increased risk of intrahepatic cholangiocarcinoma: enough to infer causality?","volume":"159","author":"La Vecchia","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5334\/aogh.3660","article-title":"Exposure to asbestos and increased intrahepatic cholangiocarcinoma risk: growing evidences of a putative causal link","volume":"88","author":"Brandi","year":"2022","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.lanepe.2024.101171_bib45","article-title":"Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: a nationwide retrospective analysis","volume":"15","author":"Neuzillet","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.32198","article-title":"Menopausal hormone therapy and risk of biliary tract cancers","volume":"75","author":"Jackson","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"9935","key":"10.1016\/j.lanepe.2024.101171_bib50","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5604\/16652681.1226927","article-title":"Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes","volume":"16","author":"Waseem","year":"2017","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"Electronic address eee, European association for the study of the L. EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gie.2013.12.031","article-title":"EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study","volume":"80","author":"Weilert","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jgh.14528","article-title":"Same-session endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary obstruction: a multicenter experience","volume":"34","author":"Jo","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib55","first-page":"1669","article-title":"Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions","volume":"71","author":"Macias","year":"2022","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib56","article-title":"Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma","volume":"6","author":"Kendall","year":"2024","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib57","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2023.07.026","article-title":"Deep learning-enabled diagnosis of liver adenocarcinoma","volume":"165","author":"Albrecht","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2024.101171_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104657","article-title":"DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours","volume":"93","author":"Dragomir","year":"2023","journal-title":"eBioMedicine"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib59","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.hpb.2018.07.021","article-title":"Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma","volume":"21","author":"Akita","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib61","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib62","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.hpb.2022.05.1341","article-title":"Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection","volume":"24","author":"Buckarma","year":"2022","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib64","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","volume":"78","author":"Villard","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.32125","article-title":"Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile","volume":"75","author":"Vedeld","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101171_bib67","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1245\/s10434-017-5833-3","article-title":"The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: a systematic review","volume":"24","author":"Basta","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib69","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12885-017-3824-1","article-title":"Shifting cancer care towards multidisciplinarity: the cancer center certification program of the German cancer society","volume":"17","author":"Kowalski","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101171_bib70","first-page":"e213","article-title":"S3-Leitlinie \u201cDiagnostik und Therapie bili\u00e4rer Karzinome\u201d \u2013 Langversion 4.0","volume":"62","author":"Gross","year":"2024","journal-title":"Z\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib71","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jhep.2024.05.041","article-title":"Integration of new technologies in the multidisciplinary approach to primary liver tumours: the next-generation tumour board","volume":"81","author":"Nault","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib72","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.annonc.2023.06.011","article-title":"ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe","volume":"34","author":"Bayle","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanepe.2024.101171_bib73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.suronc.2020.04.007","article-title":"Differences in outcome for patients with cholangiocarcinoma: racial\/ethnic disparity or socioeconomic factors?","volume":"34","author":"Lee","year":"2020","journal-title":"Surg Oncol"},{"issue":"7","key":"10.1016\/j.lanepe.2024.101171_bib74","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1245\/s10434-019-07175-4","article-title":"Intrahepatic cholangiocarcinoma: socioeconomic discrepancies, contemporary treatment approaches and survival trends from the national cancer database","volume":"26","author":"Uhlig","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.lanepe.2024.101171_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101969","article-title":"Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database","volume":"59","author":"Liao","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101171_bib76","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s11605-019-04162-8","article-title":"Association between travel distance, hospital volume, and outcomes following resection of cholangiocarcinoma","volume":"23","author":"Beal","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib77","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2018.08.004","article-title":"Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma","volume":"21","author":"Kommalapati","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.lanepe.2024.101171_bib78","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4251\/wjgo.v15.i12.2077","article-title":"Cohort study to assess geographical variation in cholangiocarcinoma treatment in England","volume":"15","author":"Jose","year":"2023","journal-title":"World J Gastrointest Oncol"},{"issue":"22","key":"10.1016\/j.lanepe.2024.101171_bib79","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100378","article-title":"How I treat biliary tract cancer","volume":"7","author":"Lamarca","year":"2022","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib81","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/liv.14856","article-title":"Nationwide treatment and outcomes of perihilar cholangiocarcinoma","volume":"41","author":"van Keulen","year":"2021","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib82","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.surg.2022.06.028","article-title":"Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma","volume":"172","author":"Keulen","year":"2022","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033576","article-title":"The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study","volume":"10","author":"Rees","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cld.2023.07.010","article-title":"Cholangiocarcinoma surveillance recommendations in patients with primary sclerosing cholangitis","volume":"28","author":"Saca","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib85","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gutjnl-2021-325178","article-title":"Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures","volume":"71","author":"Arechederra","year":"2022","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.lanepe.2024.101171_bib86","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41416-022-01738-1","article-title":"HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples","volume":"126","author":"Loi","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lanepe.2024.101171_bib87","article-title":"Application of AI on cholangiocarcinoma","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib88","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101171_bib89","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib90","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and Epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.29764","article-title":"Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma","volume":"68","author":"Nepal","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101171_bib92","first-page":"496","article-title":"Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy","volume":"73","author":"O'Rourke","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib93","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7150\/thno.63417","article-title":"Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib94","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1470-2045(17)30167-5","article-title":"Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study","volume":"18","author":"Mhatre","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib95","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib96","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1038\/s41467-022-35291-5","article-title":"Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Nat Commun"},{"issue":"4 Pt B","key":"10.1016\/j.lanepe.2024.101171_bib97","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.bbadis.2017.06.014","article-title":"Epigenome dysregulation in cholangiocarcinoma","volume":"1864","author":"O'Rourke","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101171_bib98","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2022.05.036","article-title":"Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer","volume":"77","author":"Hogdall","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101171_bib99","doi-asserted-by":"crossref","first-page":"E1827","DOI":"10.1055\/a-1551-3343","article-title":"Gastrointestinal endoscopy capacity in Eastern Africa","volume":"9","author":"Mwachiro","year":"2021","journal-title":"Endosc Int Open"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12876-023-02687-6","article-title":"Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes","volume":"23","author":"Asombang","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"10315","key":"10.1016\/j.lanepe.2024.101171_bib101","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","article-title":"The lancet commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib102","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/hep.31598","article-title":"Liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system","volume":"73","author":"Lamarca","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101171_bib103","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1245\/s10434-024-15582-5","article-title":"Comparing survival of perihilar cholangiocarcinoma after R1 resection versus palliative chemotherapy for unresected localized disease","volume":"31","author":"van Keulen","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101171_bib104","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","article-title":"Sex disparities matter in cancer development and therapy","volume":"21","author":"Haupt","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101171_bib105","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1038\/s41467-023-43749-3","article-title":"Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma","volume":"14","author":"Calderaro","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101171_bib106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41575-024-00919-y","article-title":"Artificial intelligence in liver cancer - new tools for research and patient management","volume":"21","author":"Calderaro","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:21:45Z","timestamp":1760743305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224003405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":106,"alternative-id":["S2666776224003405"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101171","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101170","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101215","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101239","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101171"}}